Pacira Pharmaceuticals Inc (PCRX.OQ)

PCRX.OQ on NASDAQ Stock Exchange Global Select Market

34.13USD
10:56am EDT
Price Change (% chg)

$0.20 (+0.59%)
Prev Close
$33.93
Open
$34.36
Day's High
$34.43
Day's Low
$33.90
Volume
23,104
Avg. Vol
115,354
52-wk High
$35.86
52-wk Low
$14.46

PCRX.OQ

Chart for PCRX.OQ

About

Pacira Pharmaceuticals, Inc. is a United States-based pharmaceutical company. The Company develops non-opioid products for postsurgical pain control. Its products include EXPAREL (bupivacaine liposome injectable suspension) is a liposome injection of bupivacaine, an amide-type local anesthetic; DepoCyt(e) (cytarabine liposome... (more)

Overall

Beta: --
Market Cap (Mil.): $1,121.29
Shares Outstanding (Mil.): 33.05
Dividend: --
Yield (%): --

Financials

  PCRX.OQ Industry Sector
P/E (TTM): -- 37.93 37.76
EPS (TTM): -1.95 -- --
ROI: -51.03 19.48 18.76
ROE: -118.06 20.17 19.59
Search Stocks

Competitors

  Price Change
DURECT Corporation (DRRX.OQ) $1.26 0.00
Hospira, Inc. (HSP.N) $41.86 +1.16
Kimberly Clark Corp (KMB.N) $98.80 0.00

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$460.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks